Industry / Colombia
Country Attractive For Clinical Investigations
October 2008 | Industry NewsNews: Colombia is fast developing as a destination for clinical investigations, and further government support in the form of new legislation and commitment is expected to add to the benefits. This was stated by the delegates at the IV National Congress for Clinical Investigation in Colombia, which was organised by the association for the advancement of clinical research (AVANZAR) in Colombia. The country offers many advantages conducive to the growth of clinical investigations. These include the continued creation of new research centres; the quality of professionals and their inclination towards research; the concentrated population, which is centred around five cities; and good patient retention rates.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
